Attached files

file filename
8-K - 8-K - Armata Pharmaceuticals, Inc.v399260_8k.htm

Exhibit 16.1

 

 

 

 

 

January 22, 2015

 

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

 

Commissioners:

 

 

We have read AmpliPhi Biosciences Corporation’s statements included under Item 4.01 of its Form 8-K filed on January 22, 2015 and we agree with such statements concerning our firm.

 

 

/s/ PBMares, LLP

 

 

PBMares, LLP